- Sections
- C - Chimie; métallurgie
- C07K - Peptides
- C07K 14/54 - Interleukines (IL)
Détention brevets de la classe C07K 14/54
Brevets de cette classe: 3315
Historique des publications depuis 10 ans
|
112
|
143
|
191
|
254
|
287
|
388
|
426
|
397
|
423
|
131
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1144 |
126 |
| Regeneron Pharmaceuticals, Inc. | 3650 |
66 |
| Xencor, Inc. | 403 |
59 |
| Altor BioScience, LLC | 63 |
45 |
| Modernatx, Inc. | 1181 |
38 |
| The Board of Trustees of the Leland Stanford Junior University | 6054 |
37 |
| The Trustees of the University of Pennsylvania | 4122 |
35 |
| Obsidian Therapeutics, Inc. | 72 |
30 |
| Board of Regents, The University of Texas System | 5370 |
29 |
| National University of Singapore | 2228 |
28 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
28 |
| Yale University | 2204 |
28 |
| City of Hope | 943 |
26 |
| Deka Biosciences, Inc. | 37 |
26 |
| Genentech, Inc. | 3742 |
25 |
| Cytune Pharma | 37 |
24 |
| Philogen S.p.A. | 120 |
23 |
| Memorial Sloan-Kettering Cancer Center | 1789 |
21 |
| ZymoGenetics, Inc. | 244 |
21 |
| Immunitybio, Inc. | 211 |
21 |
| Autres propriétaires | 2579 |